Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia
暂无分享,去创建一个
C. Doglioni | M. Marcatti | M. Clementi | N. Mancini | R. Burioni | F. Ciceri | S. Carletti | N. Ghidoli | M. Carrabba | C. Bonini | L. Vago | A. Assanelli | F. Giglio | J. Peccatori | R. Greco | M. Bernardi | C. Corti | S. Marktel | P. Scarpellini | F. Pavesi | F. Lorentino | M. Morelli | G. Levati | L. Crucitti | A. Forcina | Elisa Sala | Nicoletta Cieri | Lupo Stanghellini Mt
[1] S. Zanotti,et al. Severe sepsis and septic shock , 2013, Virulence.
[2] T. Sorrell,et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. , 2013, The Lancet. Infectious diseases.
[3] M. Arendrup,et al. ECIL-3 classical diagnostic procedures for the diagnosis of invasive fungal diseases in patients with leukaemia , 2012, Bone Marrow Transplantation.
[4] C. Viscoli,et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients , 2012, Bone Marrow Transplantation.
[5] G. Perkins,et al. Accuracy of LightCycler SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a PROSPERO systematic review protocol , 2011 .
[6] T. Calandra,et al. Multiplex Blood PCR in Combination with Blood Cultures for Improvement of Microbiological Documentation of Infection in Febrile Neutropenia , 2010, Journal of Clinical Microbiology.
[7] S. Nseir,et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[8] M. Clementi,et al. The Era of Molecular and Other Non-Culture-Based Methods in Diagnosis of Sepsis , 2010, Clinical Microbiology Reviews.
[9] T. Barbui,et al. Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO). , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] G. Castellani,et al. Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. , 2009, The Journal of infection.
[11] J. Perfect,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] M. Clementi,et al. Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies. , 2008, Journal of medical microbiology.
[13] M. Boeckh,et al. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] H. Einsele,et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time , 2005, Bone Marrow Transplantation.
[15] Richard Sylvester,et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. , 2002, The New England journal of medicine.
[16] K. Sepkowitz,et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.